ArticleCureus2025
Middle Meningeal Artery (MMA) Embolization for Recurrent Subacute Subdural Hematoma With Complete Resolution Following Transient Radiological Size Progression: A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recurrent subdural hematoma (RSDH) is a condition characterized by repeated blood accumulation beneath the dura mater, which often poses challenges in clinical management. Conventional surgical interventions, such as burr hole irrigation and drainage, are standard treatments but carry a risk of recurrence. Therefore, middle meningeal artery (MMA) embolization has recently emerged as a promising alternative to address RSDH. This case report provides an overview of an RSDH in a 56-year-old female who underwent successful MMA embolization. She initially experienced a worsening of the hematoma with an acute-on-chronic component, which later regressed significantly, leading to near-complete resolution over a one-year follow-up period. Such an outcome has not been well documented in the existing literature and therefore represents an important case study that underscores the potential of MMA embolization as a viable option for RSDH, even in cases of transient post-procedural radiological hematoma expansion. The findings emphasize the importance of careful patient monitoring and suggest that MMA embolization may offer an effective, minimally invasive alternative to surgery in select cases. It also highlights the need for ongoing research to determine the long-term effectiveness and safety of the procedure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.